Cargando…
Dendrimer-based drug delivery systems: history, challenges, and latest developments
Since the first dendrimer was reported in 1978 by Fritz Vögtle, dendrimer research has grown exponentially, from synthesis to application in the past four decades. The distinct structure characteristics of dendrimers include nanoscopic size, multi-functionalized surface, high branching, cavernous in...
Autores principales: | Wang, Juan, Li, Boxuan, Qiu, Li, Qiao, Xin, Yang, Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317453/ https://www.ncbi.nlm.nih.gov/pubmed/35879774 http://dx.doi.org/10.1186/s13036-022-00298-5 |
Ejemplares similares
-
Dendrimers for Drug Delivery
por: Chauhan, Abhay Singh
Publicado: (2018) -
Radiation‐Sensitive Dendrimer‐Based Drug Delivery System
por: Wu, Szu‐Yuan, et al.
Publicado: (2017) -
Dendrimer-Based Drug Delivery Systems for Brain Targeting
por: Zhu, Yuefei, et al.
Publicado: (2019) -
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
por: Madaan, Kanika, et al.
Publicado: (2014) -
Latest Advances in the Development of Eukaryotic Vaults as Targeted Drug Delivery Systems
por: Muñoz-Juan, Amanda, et al.
Publicado: (2019)